Cabozantinib Increases Progression–free Survival in Radioiodine–Refractory Differentiated Thyroid Cancer across Tumor Histologies and after Previous Anti–VEGF Therapy
{"title":"Cabozantinib Increases Progression–free Survival in Radioiodine–Refractory Differentiated Thyroid Cancer across Tumor Histologies and after Previous Anti–VEGF Therapy","authors":"Simone de Leo","doi":"10.1089/ct.2024;36.71-73","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":504944,"journal":{"name":"Clinical Thyroidology®","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Thyroidology®","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/ct.2024;36.71-73","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
